المؤلفون: Haitao Tu (8739369), Duanhua Ma (11441389), Yuanyuan Luo (837205), Shuifu Tang (8159547), Ying Li (38224), Gangyi Chen (381813), Liangliang Wang (580395), Zhengkun Hou (8879249), Chuangpeng Shen (11441392), Huan Lu (641668), Xun Zhuang (327636), Liangyou Zhang (11441395)

مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Genetics, Molecular Biology, Pharmacology, Marine Biology, Virology, Chemical Sciences not elsewhere classified, CRF, quercetin, pik3r1, pi3k/akt

Relation: https://figshare.com/articles/journal_contribution/Quercetin_alleviates_chronic_renal_failure_by_targeting_the_PI3k_Akt_pathway/16628743

الاتاحة: https://doi.org/10.6084/m9.figshare.16628743.v1

المؤلفون: Wei Mao (304011), Nizhi Yang (6914279), Lei Zhang (38117), Chuang Li (2010226), Yifan Wu (1702936), Wenwei Ouyang (2504665), Peng Xu (17962), Chuan Zou (723881), Chunpeng Pei (10051751), Wei Shi (68167), Jihong Zhan (10051754), Hongtao Yang (6171521), Hongyu Chen (105612), Xiaoqin Wang (12030), Yun Tian (411157), Fang Yuan (96264), Wei Sun (93580), Guoliang Xiong (757986), Ming Chen (115604), Jianguo Guan (1462282), Shuifu Tang (8159547), Chunyan Zhang (30676), Yuning Liu (4350469), Yueyi Deng (509339), Qizhan Lin (723886), Fuhua Lu (837477), Weihong Hong (10051757), Aicheng Yang (4920943), Jingai Fang (10051760), Jiazhen Rao (10051763), Lixin Wang (343011), Kun Bao (2048122), Feng Lin (23861), Yuan Xu (161775), Zhaoyu Lu (837475), Guobin Su (723883), La Zhang (6641339), David W Johnson (8277471), Daixin Zhao (4920946), Haijing Hou (10051766), Lizhe Fu (10051769), Xinfeng Guo (578077), Lihong Yang (7196), Xindong Qin (10051772), Zehuai Wen (2504662), Xusheng Liu (237726)

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, traditional Chinese medicine, losartan, chronic kidney disease, randomized controlled trial, glomerular filtration rate

Relation: https://figshare.com/articles/dataset/datasheet2_Bupi_Yishen_Formula_Versus_Losartan_for_Non-Diabetic_Stage_4_Chronic_Kidney_Disease_A_Randomized_Controlled_Trial_doc/14095805

الاتاحة: https://doi.org/10.3389/fphar.2020.627185.s002

المؤلفون: Wei Mao (304011), Nizhi Yang (6914279), Lei Zhang (38117), Chuang Li (2010226), Yifan Wu (1702936), Wenwei Ouyang (2504665), Peng Xu (17962), Chuan Zou (723881), Chunpeng Pei (10051751), Wei Shi (68167), Jihong Zhan (10051754), Hongtao Yang (6171521), Hongyu Chen (105612), Xiaoqin Wang (12030), Yun Tian (411157), Fang Yuan (96264), Wei Sun (93580), Guoliang Xiong (757986), Ming Chen (115604), Jianguo Guan (1462282), Shuifu Tang (8159547), Chunyan Zhang (30676), Yuning Liu (4350469), Yueyi Deng (509339), Qizhan Lin (723886), Fuhua Lu (837477), Weihong Hong (10051757), Aicheng Yang (4920943), Jingai Fang (10051760), Jiazhen Rao (10051763), Lixin Wang (343011), Kun Bao (2048122), Feng Lin (23861), Yuan Xu (161775), Zhaoyu Lu (837475), Guobin Su (723883), La Zhang (6641339), David W Johnson (8277471), Daixin Zhao (4920946), Haijing Hou (10051766), Lizhe Fu (10051769), Xinfeng Guo (578077), Lihong Yang (7196), Xindong Qin (10051772), Zehuai Wen (2504662), Xusheng Liu (237726)

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, traditional Chinese medicine, losartan, chronic kidney disease, randomized controlled trial, glomerular filtration rate

Relation: https://figshare.com/articles/dataset/datasheet1_Bupi_Yishen_Formula_Versus_Losartan_for_Non-Diabetic_Stage_4_Chronic_Kidney_Disease_A_Randomized_Controlled_Trial_docx/14095803

الاتاحة: https://doi.org/10.3389/fphar.2020.627185.s001

المؤلفون: Wei Mao (304011), Nizhi Yang (6914279), Lei Zhang (38117), Chuang Li (2010226), Yifan Wu (1702936), Wenwei Ouyang (2504665), Peng Xu (17962), Chuan Zou (723881), Chunpeng Pei (10051751), Wei Shi (68167), Jihong Zhan (10051754), Hongtao Yang (6171521), Hongyu Chen (105612), Xiaoqin Wang (12030), Yun Tian (411157), Fang Yuan (96264), Wei Sun (93580), Guoliang Xiong (757986), Ming Chen (115604), Jianguo Guan (1462282), Shuifu Tang (8159547), Chunyan Zhang (30676), Yuning Liu (4350469), Yueyi Deng (509339), Qizhan Lin (723886), Fuhua Lu (837477), Weihong Hong (10051757), Aicheng Yang (4920943), Jingai Fang (10051760), Jiazhen Rao (10051763), Lixin Wang (343011), Kun Bao (2048122), Feng Lin (23861), Yuan Xu (161775), Zhaoyu Lu (837475), Guobin Su (723883), La Zhang (6641339), David W Johnson (8277471), Daixin Zhao (4920946), Haijing Hou (10051766), Lizhe Fu (10051769), Xinfeng Guo (578077), Lihong Yang (7196), Xindong Qin (10051772), Zehuai Wen (2504662), Xusheng Liu (237726)

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, traditional Chinese medicine, losartan, chronic kidney disease, randomized controlled trial, glomerular filtration rate

Relation: https://figshare.com/articles/dataset/datasheet1_Bupi_Yishen_Formula_Versus_Losartan_for_Non-Diabetic_Stage_4_Chronic_Kidney_Disease_A_Randomized_Controlled_Trial_docx/13664006

الاتاحة: https://doi.org/10.3389/fphar.2020.627185.s001

المؤلفون: Wei Mao (304011), Nizhi Yang (6914279), Lei Zhang (38117), Chuang Li (2010226), Yifan Wu (1702936), Wenwei Ouyang (2504665), Peng Xu (17962), Chuan Zou (723881), Chunpeng Pei (10051751), Wei Shi (68167), Jihong Zhan (10051754), Hongtao Yang (6171521), Hongyu Chen (105612), Xiaoqin Wang (12030), Yun Tian (411157), Fang Yuan (96264), Wei Sun (93580), Guoliang Xiong (757986), Ming Chen (115604), Jianguo Guan (1462282), Shuifu Tang (8159547), Chunyan Zhang (30676), Yuning Liu (4350469), Yueyi Deng (509339), Qizhan Lin (723886), Fuhua Lu (837477), Weihong Hong (10051757), Aicheng Yang (4920943), Jingai Fang (10051760), Jiazhen Rao (10051763), Lixin Wang (343011), Kun Bao (2048122), Feng Lin (23861), Yuan Xu (161775), Zhaoyu Lu (837475), Guobin Su (723883), La Zhang (6641339), David W Johnson (8277471), Daixin Zhao (4920946), Haijing Hou (10051766), Lizhe Fu (10051769), Xinfeng Guo (578077), Lihong Yang (7196), Xindong Qin (10051772), Zehuai Wen (2504662), Xusheng Liu (237726)

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, traditional Chinese medicine, losartan, chronic kidney disease, randomized controlled trial, glomerular filtration rate

Relation: https://figshare.com/articles/dataset/datasheet2_Bupi_Yishen_Formula_Versus_Losartan_for_Non-Diabetic_Stage_4_Chronic_Kidney_Disease_A_Randomized_Controlled_Trial_doc/13664009

الاتاحة: https://doi.org/10.3389/fphar.2020.627185.s002